1988
DOI: 10.1111/j.1600-0773.1988.tb00899.x
|View full text |Cite
|
Sign up to set email alerts
|

Interactions between Calcium Channel Blockers and Non‐Cardiovascular Drugs: Interactions with Anticancer Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
2

Year Published

1990
1990
2001
2001

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 25 publications
0
2
0
2
Order By: Relevance
“…6. Apparently, the inhibition of the slow calcium influx as a physiological effect of the calcium antagonists plays no crucial part in the reversal of multi drug resistance [5,29],…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…6. Apparently, the inhibition of the slow calcium influx as a physiological effect of the calcium antagonists plays no crucial part in the reversal of multi drug resistance [5,29],…”
Section: Discussionmentioning
confidence: 99%
“…Meanwhile, a range of so-called 'chemosensitizing agents' (table 1) has been identified which enhances the antitumorous efficacy of cytotoxic medicaments such as the vinca-alkaloids or the anthracyclines in vitro by inac tivation of the transmembraneous efflux [5,6]. Although most of these substances cannot be applied to human beings for the purpose of reversing MDR for reason of their pharmacological or toxological properties, initial clinical trials on some tumors with verapamil [7][8][9][10] derivatives such as nitrendipine (NIT), nimodipine (NIM) and the new R-stereoisomer of verapamil (R-VPM).…”
Section: Introductionmentioning
confidence: 99%
“…5. Sicher ist, daß die Blockade des langsamen Kalziumeinstroms als physiologische Wirkung der Kalziumantagonisten keine Rolle bei der Überwindung von Vielfach-Resistenz spielt (1,16).…”
Section: Diskussionunclassified
“…1), die durch Behinderung des transmembranösen Effluxes die antitumorale Wirkung klassischer Chemotherapeutika, wie z.B. der Vinca-Alkaloide oder der Anthrazykline, in vitro erhöhen können (1,17). Obwohl die meisten dieser Substanzen aufgrund ihrer pharmakologischen oder toxikologischen Eigenschaften für eine Verwendung als Resistenzdurchbrecher beim Menschen nicht in Betracht kommen, liegen bereits erste klinische Ergebnisse mit Verapamil (2,23,24,27), Chinidin (7), Amiodaron (7) und Amphotericin B (29) bei einigen Tumorarten vor.…”
unclassified